APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-Layer Interferometry (BLI) Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bio-Layer Interferometry (BLI) Service Market Analysis and Forecast 2026-2032

3 May 2026190 pages

Choose your research edition.

Industry ResearchBio-Layer Interferometry (BLI) Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-Layer Interferometry (BLI) Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Bio-Layer Interferometry (BLI) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-Layer Interferometry (BLI) Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-Layer Interferometry (BLI) Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Bio-Layer Interferometry (BLI) Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bio-Layer Interferometry (BLI) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bio-Layer Interferometry (BLI) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bio-Layer Interferometry (BLI) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bio-Layer Interferometry (BLI) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bio-Layer Interferometry (BLI) Service include Ichor Life Sciences, Inc, Creative BioMart, GenScript, Rockland Immunochemicals, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bio-Layer Interferometry (BLI) Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bio-Layer Interferometry (BLI) Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Bio-Layer Interferometry (BLI) Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bio-Layer Interferometry (BLI) Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bio-Layer Interferometry (BLI) Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bio-Layer Interferometry (BLI) Service revenue, projected growth trends, production technology, application and end-user industry.

Bio-Layer Interferometry (BLI) Service Segment by Company

Ichor Life Sciences, Inc

Creative BioMart

GenScript

Rockland Immunochemicals

BPS Bioscience, Inc

Creative Proteomics

Creative Biostructure

Profacgen

Creative Biolabs

KMD Bioscience Co., Ltd

2bind GmbH

Sino Biological, Inc

Bio-Layer Interferometry (BLI) Service Segment by Type

General Sensors

Capture Sensors

Antibody Sensors

Others

Bio-Layer Interferometry (BLI) Service Segment by Application

Affinity and Kinetic Analysis

Pharmaceutical Assay Development

Protein Concentration Measurement

Others

Bio-Layer Interferometry (BLI) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-Layer Interferometry (BLI) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-Layer Interferometry (BLI) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-Layer Interferometry (BLI) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bio-Layer Interferometry (BLI) Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bio-Layer Interferometry (BLI) Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-Layer Interferometry (BLI) Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. General Sensors Major Player Table 3. Capture Sensors Major Player Table 4. Antibody Sensors Major Player Table 5. Others Major Player Table 6. Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Affinity and Kinetic Analysis Major Player Table 8. Pharmaceutical Assay Development Major Player Table 9. Protein Concentration Measurement Major Player Table 10. Others Major Player Table 11. Bio-Layer Interferometry (BLI) Service Industry Trends Table 12. Bio-Layer Interferometry (BLI) Service Industry Drivers Table 13. Bio-Layer Interferometry (BLI) Service Industry Opportunities and Challenges Table 14. Bio-Layer Interferometry (BLI) Service Industry Restraints Table 15. Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Bio-Layer Interferometry (BLI) Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Bio-Layer Interferometry (BLI) Service Market Share by Region (2021-2026) Table 18. Global Bio-Layer Interferometry (BLI) Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Bio-Layer Interferometry (BLI) Service Market Share by Region (2027-2032) Table 20. Global Bio-Layer Interferometry (BLI) Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Players (2021-2026) Table 22. Global Bio-Layer Interferometry (BLI) Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Bio-Layer Interferometry (BLI) Service Key Players Headquarters & Area Served Table 24. Global Bio-Layer Interferometry (BLI) Service Players, Product Type & Application Table 25. Global Bio-Layer Interferometry (BLI) Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Bio-Layer Interferometry (BLI) Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Bio-Layer Interferometry (BLI) Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Type (2021-2026) Table 32. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Type (2027-2032) Table 33. Global Bio-Layer Interferometry (BLI) Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Application (2021-2026) Table 37. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Application (2027-2032) Table 38. Ichor Life Sciences, Inc Company Information Table 39. Ichor Life Sciences, Inc Business Overview Table 40. Ichor Life Sciences, Inc Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Ichor Life Sciences, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio Table 42. Ichor Life Sciences, Inc Recent Development Table 43. Creative BioMart Company Information Table 44. Creative BioMart Business Overview Table 45. Creative BioMart Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Creative BioMart Bio-Layer Interferometry (BLI) Service Product Portfolio Table 47. Creative BioMart Recent Development Table 48. GenScript Company Information Table 49. GenScript Business Overview Table 50. GenScript Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GenScript Bio-Layer Interferometry (BLI) Service Product Portfolio Table 52. GenScript Recent Development Table 53. Rockland Immunochemicals Company Information Table 54. Rockland Immunochemicals Business Overview Table 55. Rockland Immunochemicals Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Rockland Immunochemicals Bio-Layer Interferometry (BLI) Service Product Portfolio Table 57. Rockland Immunochemicals Recent Development Table 58. BPS Bioscience, Inc Company Information Table 59. BPS Bioscience, Inc Business Overview Table 60. BPS Bioscience, Inc Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. BPS Bioscience, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio Table 62. BPS Bioscience, Inc Recent Development Table 63. Creative Proteomics Company Information Table 64. Creative Proteomics Business Overview Table 65. Creative Proteomics Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Creative Proteomics Bio-Layer Interferometry (BLI) Service Product Portfolio Table 67. Creative Proteomics Recent Development Table 68. Creative Biostructure Company Information Table 69. Creative Biostructure Business Overview Table 70. Creative Biostructure Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Creative Biostructure Bio-Layer Interferometry (BLI) Service Product Portfolio Table 72. Creative Biostructure Recent Development Table 73. Profacgen Company Information Table 74. Profacgen Business Overview Table 75. Profacgen Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Profacgen Bio-Layer Interferometry (BLI) Service Product Portfolio Table 77. Profacgen Recent Development Table 78. Creative Biolabs Company Information Table 79. Creative Biolabs Business Overview Table 80. Creative Biolabs Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Creative Biolabs Bio-Layer Interferometry (BLI) Service Product Portfolio Table 82. Creative Biolabs Recent Development Table 83. KMD Bioscience Co., Ltd Company Information Table 84. KMD Bioscience Co., Ltd Business Overview Table 85. KMD Bioscience Co., Ltd Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. KMD Bioscience Co., Ltd Bio-Layer Interferometry (BLI) Service Product Portfolio Table 87. KMD Bioscience Co., Ltd Recent Development Table 88. 2bind GmbH Company Information Table 89. 2bind GmbH Business Overview Table 90. 2bind GmbH Bio-Layer Interferometry (BLI) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. 2bind GmbH Bio-Layer Interferometry (BLI) Service Product Portfolio Table 92. 2bind GmbH Recent Development Table 93. Sino Biological, Inc Company Information Table 94. Sino Biological, Inc Business Overview Table 95. Sino Biological, Inc Bio-Layer Interferometry (BLI) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Sino Biological, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio Table 97. Sino Biological, Inc Recent Development Table 98. North America Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026) & (US$ Million) Table 104. North America Bio-Layer Interferometry (BLI) Service Revenue by Country (US$ Million) & (2027-2032) Table 105. Europe Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (US$ Million) & (2027-2032) Table 112. China Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 113. China Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 114. China Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 115. China Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 117. Asia Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 118. Asia Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 119. Asia Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Bio-Layer Interferometry (BLI) Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia Bio-Layer Interferometry (BLI) Service Revenue by Region (US$ Million) & (2021-2026) Table 122. Asia Bio-Layer Interferometry (BLI) Service Revenue by Region (US$ Million) & (2027-2032) Table 123. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026) & (US$ Million) Table 124. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032) & (US$ Million) Table 125. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026) & (US$ Million) Table 126. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032) & (US$ Million) Table 127. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026) & (US$ Million) Table 129. SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (US$ Million) & (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Bio-Layer Interferometry (BLI) Service Image Figure 2. Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-Layer Interferometry (BLI) Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. General Sensors Image Figure 5. Capture Sensors Image Figure 6. Antibody Sensors Image Figure 7. Others Image Figure 8. Global Bio-Layer Interferometry (BLI) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Bio-Layer Interferometry (BLI) Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Affinity and Kinetic Analysis Image Figure 11. Pharmaceutical Assay Development Image Figure 12. Protein Concentration Measurement Image Figure 13. Others Image Figure 14. Global Bio-Layer Interferometry (BLI) Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Bio-Layer Interferometry (BLI) Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Bio-Layer Interferometry (BLI) Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Bio-Layer Interferometry (BLI) Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Bio-Layer Interferometry (BLI) Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Type (2021-2032) Figure 22. Global Bio-Layer Interferometry (BLI) Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Application (2021-2032) Figure 25. North America Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032) Figure 27. North America Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032) Figure 28. North America Bio-Layer Interferometry (BLI) Service Revenue Share by Country (2021-2032) Figure 29. United States Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032) Figure 34. Europe Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032) Figure 35. Europe Bio-Layer Interferometry (BLI) Service Revenue Share by Country (2021-2032) Figure 36. Germany Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032) Figure 46. China Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032) Figure 47. Asia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032) Figure 49. Asia Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032) Figure 50. Asia Bio-Layer Interferometry (BLI) Service Revenue Share by Region (2021-2032) Figure 51. Japan Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Bio-Layer Interferometry (BLI) Service Revenue Share by Country (2021-2032) Figure 61. Brazil Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Bio-Layer Interferometry (BLI) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • General Sensors
  • Capture Sensors
  • Antibody Sensors
  • Others
Applications
  • Affinity and Kinetic Analysis
  • Pharmaceutical Assay Development
  • Protein Concentration Measurement
  • Others
Companies covered
  • Ichor Life Sciences, Inc
  • Creative BioMart
  • GenScript
  • Rockland Immunochemicals
  • BPS Bioscience, Inc
  • Creative Proteomics
  • Creative Biostructure
  • Profacgen
  • Creative Biolabs
  • KMD Bioscience Co., Ltd
  • 2bind GmbH
  • Sino Biological, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bio-Layer Interferometry (BLI) Service Market by Type
  3. 1.2.1 Global Bio-Layer Interferometry (BLI) Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 General Sensors
  5. 1.2.3 Capture Sensors
  6. 1.2.4 Antibody Sensors
  7. 1.2.5 Others
  8. 1.3 Bio-Layer Interferometry (BLI) Service Market by Application
  9. 1.3.1 Global Bio-Layer Interferometry (BLI) Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Affinity and Kinetic Analysis
  11. 1.3.3 Pharmaceutical Assay Development
  12. 1.3.4 Protein Concentration Measurement
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Bio-Layer Interferometry (BLI) Service Market Dynamics
  1. 2.1 Bio-Layer Interferometry (BLI) Service Industry Trends
  2. 2.2 Bio-Layer Interferometry (BLI) Service Industry Drivers
  3. 2.3 Bio-Layer Interferometry (BLI) Service Industry Opportunities and Challenges
  4. 2.4 Bio-Layer Interferometry (BLI) Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bio-Layer Interferometry (BLI) Service Market Perspective (2021-2032)
  2. 3.2 Global Bio-Layer Interferometry (BLI) Service Growth Trends by Region
  3. 3.2.1 Global Bio-Layer Interferometry (BLI) Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bio-Layer Interferometry (BLI) Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Bio-Layer Interferometry (BLI) Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bio-Layer Interferometry (BLI) Service Revenue by Players
  2. 4.1.1 Global Bio-Layer Interferometry (BLI) Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bio-Layer Interferometry (BLI) Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bio-Layer Interferometry (BLI) Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bio-Layer Interferometry (BLI) Service Key Players Headquarters & Area Served
  7. 4.4 Global Bio-Layer Interferometry (BLI) Service Players, Product Type & Application
  8. 4.5 Global Bio-Layer Interferometry (BLI) Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bio-Layer Interferometry (BLI) Service Market CR5 and HHI
  11. 4.6.3 2025 Bio-Layer Interferometry (BLI) Service Tier 1, Tier 2, and Tier 3
5 Bio-Layer Interferometry (BLI) Service Market Size by Type
  1. 5.1 Global Bio-Layer Interferometry (BLI) Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 5.3 Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Type (2021-2032)
6 Bio-Layer Interferometry (BLI) Service Market Size by Application
  1. 6.1 Global Bio-Layer Interferometry (BLI) Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  3. 6.3 Global Bio-Layer Interferometry (BLI) Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Ichor Life Sciences, Inc
  2. 7.1.1 Ichor Life Sciences, Inc Company Information
  3. 7.1.2 Ichor Life Sciences, Inc Business Overview
  4. 7.1.3 Ichor Life Sciences, Inc Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Ichor Life Sciences, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio
  6. 7.1.5 Ichor Life Sciences, Inc Recent Developments
  7. 7.2 Creative BioMart
  8. 7.2.1 Creative BioMart Company Information
  9. 7.2.2 Creative BioMart Business Overview
  10. 7.2.3 Creative BioMart Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative BioMart Bio-Layer Interferometry (BLI) Service Product Portfolio
  12. 7.2.5 Creative BioMart Recent Developments
  13. 7.3 GenScript
  14. 7.3.1 GenScript Company Information
  15. 7.3.2 GenScript Business Overview
  16. 7.3.3 GenScript Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GenScript Bio-Layer Interferometry (BLI) Service Product Portfolio
  18. 7.3.5 GenScript Recent Developments
  19. 7.4 Rockland Immunochemicals
  20. 7.4.1 Rockland Immunochemicals Company Information
  21. 7.4.2 Rockland Immunochemicals Business Overview
  22. 7.4.3 Rockland Immunochemicals Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Rockland Immunochemicals Bio-Layer Interferometry (BLI) Service Product Portfolio
  24. 7.4.5 Rockland Immunochemicals Recent Developments
  25. 7.5 BPS Bioscience, Inc
  26. 7.5.1 BPS Bioscience, Inc Company Information
  27. 7.5.2 BPS Bioscience, Inc Business Overview
  28. 7.5.3 BPS Bioscience, Inc Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BPS Bioscience, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio
  30. 7.5.5 BPS Bioscience, Inc Recent Developments
  31. 7.6 Creative Proteomics
  32. 7.6.1 Creative Proteomics Company Information
  33. 7.6.2 Creative Proteomics Business Overview
  34. 7.6.3 Creative Proteomics Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Creative Proteomics Bio-Layer Interferometry (BLI) Service Product Portfolio
  36. 7.6.5 Creative Proteomics Recent Developments
  37. 7.7 Creative Biostructure
  38. 7.7.1 Creative Biostructure Company Information
  39. 7.7.2 Creative Biostructure Business Overview
  40. 7.7.3 Creative Biostructure Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biostructure Bio-Layer Interferometry (BLI) Service Product Portfolio
  42. 7.7.5 Creative Biostructure Recent Developments
  43. 7.8 Profacgen
  44. 7.8.1 Profacgen Company Information
  45. 7.8.2 Profacgen Business Overview
  46. 7.8.3 Profacgen Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Profacgen Bio-Layer Interferometry (BLI) Service Product Portfolio
  48. 7.8.5 Profacgen Recent Developments
  49. 7.9 Creative Biolabs
  50. 7.9.1 Creative Biolabs Company Information
  51. 7.9.2 Creative Biolabs Business Overview
  52. 7.9.3 Creative Biolabs Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biolabs Bio-Layer Interferometry (BLI) Service Product Portfolio
  54. 7.9.5 Creative Biolabs Recent Developments
  55. 7.10 KMD Bioscience Co., Ltd
  56. 7.10.1 KMD Bioscience Co., Ltd Company Information
  57. 7.10.2 KMD Bioscience Co., Ltd Business Overview
  58. 7.10.3 KMD Bioscience Co., Ltd Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 KMD Bioscience Co., Ltd Bio-Layer Interferometry (BLI) Service Product Portfolio
  60. 7.10.5 KMD Bioscience Co., Ltd Recent Developments
  61. 7.11 2bind GmbH
  62. 7.11.1 2bind GmbH Company Information
  63. 7.11.2 2bind GmbH Business Overview
  64. 7.11.3 2bind GmbH Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 2bind GmbH Bio-Layer Interferometry (BLI) Service Product Portfolio
  66. 7.11.5 2bind GmbH Recent Developments
  67. 7.12 Sino Biological, Inc
  68. 7.12.1 Sino Biological, Inc Company Information
  69. 7.12.2 Sino Biological, Inc Business Overview
  70. 7.12.3 Sino Biological, Inc Bio-Layer Interferometry (BLI) Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sino Biological, Inc Bio-Layer Interferometry (BLI) Service Product Portfolio
  72. 7.12.5 Sino Biological, Inc Recent Developments
8 North America
  1. 8.1 North America Bio-Layer Interferometry (BLI) Service Revenue (2021-2032)
  2. 8.2 North America Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032)
  5. 8.3 North America Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032)
  9. 8.5 North America Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Bio-Layer Interferometry (BLI) Service Revenue by Country
  11. 8.6.1 North America Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Bio-Layer Interferometry (BLI) Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bio-Layer Interferometry (BLI) Service Revenue (2021-2032)
  2. 9.2 Europe Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032)
  5. 9.3 Europe Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032)
  9. 9.5 Europe Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bio-Layer Interferometry (BLI) Service Revenue by Country
  11. 9.6.1 Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bio-Layer Interferometry (BLI) Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bio-Layer Interferometry (BLI) Service Revenue (2021-2032)
  2. 10.2 China Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 10.2.1 China Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026)
  4. 10.2.2 China Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032)
  5. 10.3 China Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032)
  6. 10.4 China Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  7. 10.4.1 China Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026)
  8. 10.4.2 China Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032)
  9. 10.5 China Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bio-Layer Interferometry (BLI) Service Revenue (2021-2032)
  2. 11.2 Asia Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032)
  5. 11.3 Asia Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032)
  9. 11.5 Asia Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bio-Layer Interferometry (BLI) Service Revenue by Country
  11. 11.6.1 Asia Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bio-Layer Interferometry (BLI) Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bio-Layer Interferometry (BLI) Service Revenue (2021-2032)
  2. 12.2 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bio-Layer Interferometry (BLI) Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bio-Layer Interferometry (BLI) Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country
  11. 12.6.1 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bio-Layer Interferometry (BLI) Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst